ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,552Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 2888

$1.32M Total Retail Price of All Prescriptions

Rank: 107 out of 2888

708 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 708 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 20,121 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,246 955 1 2
LEVOTHYROXINE SODIUM 978 818 2 1
LISINOPRIL 939 675 3 3
AMLODIPINE BESYLATE 879 713 4 5
FUROSEMIDE 686 564 5 6
HYDROCODONE-ACETAMINOPHEN 610 511 S3 6 4
OMEPRAZOLE 545 426 7 7
CITALOPRAM HBR 495 377 8 24
METOPROLOL TARTRATE 477 403 9 10
DONEPEZIL HCL 440 426 10 26
RANITIDINE HCL 411 298 11 56
METFORMIN HCL 375 250 12 8
LOVASTATIN 363 295 13 41
POTASSIUM CHLORIDE 361 324 14 14
ZOLPIDEM TARTRATE 358 262 15 17
TRAMADOL HCL 356 278 16 16
CARVEDILOL 335 288 17 21
NEXIUM 293 198 18 19
RISPERIDONE 280 238 19 72
GABAPENTIN 280 185 19 13
ATORVASTATIN CALCIUM 248 210 21 9
WARFARIN SODIUM 223 207 22 22
HYDROCHLOROTHIAZIDE 219 170 23 15
NAMENDA 216 204 24 34
MIRTAZAPINE 214 192 25 54
CLOPIDOGREL 211 182 26 30
MELOXICAM 205 166 27 31
CYMBALTA 194 138 28 44
OXYBUTYNIN CHLORIDE ER 193 192 29 132
METOPROLOL SUCCINATE 181 149 30 11
GLIPIZIDE 180 127 31 50
CARBIDOPA-LEVODOPA 171 111 32 113
LOSARTAN POTASSIUM 165 131 33 18
GLIMEPIRIDE 162 116 34 36
CEPHALEXIN 159 122 35 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 122 36 28
TRAZODONE HCL 152 111 37 43
ALENDRONATE SODIUM 151 127 38 23
ISOSORBIDE MONONITRATE ER 150 137 39 51
CYCLOBENZAPRINE HCL 143 120 R 40 68
BENAZEPRIL HCL 142 115 41 77
LEVEMIR 139 89 42 135
SERTRALINE HCL 137 106 43 27
KLOR-CON M20 137 104 43 90
PRAVASTATIN SODIUM 137 101 43 12
PLAVIX 136 121 46 40
CLONIDINE HCL 135 90 47 39
PANTOPRAZOLE SODIUM 133 107 48 33
TAMSULOSIN HCL 129 99 49 29
CIPROFLOXACIN HCL 125 108 50 47
LEVETIRACETAM 125 65 50 103
FAMOTIDINE 122 106 52 75
DIOVAN 120 100 53 35
LANTUS 114 77 54 45
AMITRIPTYLINE HCL 109 56 R 55 74
NOVOLOG 108 84 56 114
ALLOPURINOL 106 79 57 37
AMLODIPINE BESYLATE-BENAZEPRIL 104 81 58 67
NITROFURANTOIN 103 80 59 241
PHENYTOIN SODIUM EXTENDED 102 63 60 128
LYRICA 98 78 61 69
KLOR-CON M10 96 82 62 118
AGGRENOX 95 74 63 223
VESICARE 92 85 64 154
ESCITALOPRAM OXALATE 91 76 65 62
SPIRIVA 91 75 65 79
POLYETHYLENE GLYCOL 3350 90 68 67 93
FLUOXETINE HCL 88 67 68 83
ATENOLOL 87 68 69 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 72 69 88
JANUVIA 86 63 71 48
EXELON 84 84 72 106
GLYBURIDE 84 28 R 72 58
ADVAIR DISKUS 82 79 74 60
BACLOFEN 80 31 75 121
METHYLPREDNISOLONE 80 65 75 101
PROAIR HFA 80 67 75 71
PAROXETINE HCL 75 66 78 84
SPIRONOLACTONE 75 30 78 70
DILTIAZEM ER 75 75 78 182
CELEBREX 74 60 81 89
DIVALPROEX SODIUM 74 51 81 100
JANTOVEN 72 72 83 163
VYTORIN 72 44 83 155
DETROL LA 72 60 83 192
QUETIAPINE FUMARATE 69 60 86 66
RAMIPRIL 68 57 87 73
FLUTICASONE PROPIONATE 68 55 87 32
NITROFURANTOIN MONO-MACRO 67 60 89 162
LIDODERM 66 59 90 105
LEVOFLOXACIN 66 60 90 57
LANSOPRAZOLE 63 40 92 213
DIGOXIN 63 52 92 55
COMBIVENT 63 53 92 177
ROPINIROLE HCL 62 37 95 115
LABETALOL HCL 61 37 96 180
MUPIROCIN 61 51 96 184
CEFTRIAXONE 59 57 98 281
TORSEMIDE 59 46 98 158
PREDNISONE 59 52 98 42
NYSTATIN 59 48 98 178
NOVOLOG MIX 70-30 58 47 102 209
VENLAFAXINE HCL ER 58 53 102 120
CARBAMAZEPINE 56 35 104 217
ZONISAMIDE 56 24 104 568
TRICOR 55 45 106 91
HYDRALAZINE HCL 54 54 107 59
FLUCONAZOLE 53 36 108 199
VERAPAMIL ER 53 49 108 104
ABILIFY 53 18 108 172
PROMETHAZINE HCL 53 44 R 108 96
DIVALPROEX SODIUM ER 53 28 108 185
DIOVAN HCT 52 49 113 61
HYDROXYZINE HCL 52 40 R 113 174
COLCRYS 51 39 115 295
AMOX TR-POTASSIUM CLAVULANATE 51 44 115 112
LATANOPROST 51 51 115 197
LEVOXYL 51 32 115 208
FENOFIBRATE 50 45 119 65
TRILIPIX 50 38 119 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.